InvestorsHub Logo
Followers 5
Posts 69
Boards Moderated 0
Alias Born 02/19/2014

Re: None

Wednesday, 03/12/2014 9:42:21 AM

Wednesday, March 12, 2014 9:42:21 AM

Post# of 32025
Still cannot believe that the sentiment on this is bearish and people are making short positions...

This drug will be approved. Like George Rho pointed out, these panelists are experts who are more worried about their long term reputation than "pharmaceutical politics".

Whether or not they favor any of these larger companies will not matter if the drug proves effective by their set standards, especially when many diabetics have adamantly expressed their need of a new way to get their insulin dosages.

Even the researchers who work for Pfizer and helped launch Exubera are rooting for Mannkind.

I just loaded up 3k shares @5.62 and I'm ready to rumble
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News